Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
- Status
- RECRUITING
- Phase
- PHASE2
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
- Status
- TERMINATED
- Phase
- PHASE1
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
- Status
- RECRUITING
- Phase
- N/A
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
- Status
- UNKNOWN
- Phase
- NA
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A
Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- N/A
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Safe Accelerated Venetoclax Escalation in CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
- Status
- RECRUITING
- Phase
- N/A
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Status
- RECRUITING
- Phase
- PHASE1
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ALICIA (Acalabrutinib in CLL Therapy)
- Status
- COMPLETED
- Phase
- N/A